Mary Shannon

Oligodeoxynucleotide CpG 7909 Delivered as Intravenous Infusion Demonstrates Immunologic Modulation in Patients With Previously Treated Non-Hodgkin Lymphoma

Brian K. Link, Zuhair K. Ballas, Daniel Weisdorf et al. · Journal of Immunotherapy · 2006 · 154 citations

Medicine, Immunology, Pharmacology +17

Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results

David M. Lubaroff, Badrinath R. Konety, Brian K. Link et al. · Clinical Cancer Research · 2009 · 90 citations

Veterinary Medicine, Immunology, Oncology +17

A phase I and II study of m-AMSA in acute leukaemia

M L Slevin, Mary Shannon, H. G. Prentice et al. · Cancer Chemotherapy and Pharmacology · 1981 · 30 citations

Medicine, Hematology, Immunology +9

Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy

Vikram K. Chand, Brian K. Link, Justine M. Ritchie et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 28 citations

Medicine, Oncology, Pharmacotherapy +17

Phase II Trial of Remitogen™ (Humanized 1D10) Monoclonal Antibody Targeting Class II in Patients with Relapsed Low-Grade or Follicular Lymphoma

Kevin S. Brown, Daniel Levitt, Mary Shannon et al. · Clinical Lymphoma · 2001 · 27 citations

Medicine, Hematology, Oncology +16